Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.
about
Pharmacotherapies for obesity: past, current, and future therapiesThe use of lorcaserin in the management of obesity: a critical appraisalBraking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functionsHub and switches: endocannabinoid signalling in midbrain dopamine neuronsAnti-Obesity Drugs: A Review about Their Effects and SafetyReceptor heteromerization and drug discovery.Cannabinoid receptor type-1: breaking the dogmasAn Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for ObesityMedicinal Plants and Their Inhibitory Activities against Pancreatic Lipase: A ReviewWeight management in obesity - past and presentThe hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intakeTargeting NADPH oxidases in vascular pharmacologySelf-directed interventions to promote weight loss: a systematic review of reviewsThe role of endocannabinoids system in fatty liver disease and therapeutic potentialsCannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia PharmacotherapyTesofensine – a novel potent weight loss medicineInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionAdenosine-cannabinoid receptor interactions. Implications for striatal functionDietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesityObesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorshipPharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in MuscleEvaluation of a Mathematical Model of Rat Body Weight Regulation in Application to Caloric Restriction and Drug Treatment StudiesEndocannabinoid-mediated synaptic plasticity and addiction-related behaviorAnalysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffoldsObesity: Current and potential pharmacotherapeutics and targets.Pharmacotherapies for Overeating and Obesity.New and emerging drug molecules against obesity.The future role of gut hormones in the treatment of obesityDevelopmental regulation of fear learning and anxiety behavior by endocannabinoids.Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate DiscussedA neurocognitive model for understanding treatment action in depressionTackling obesity: new therapeutic agents for assisted weight loss.Stress regulates endocannabinoid-CB1 receptor signaling.Assessment of endothelial dysfunction in childhood obesity and clinical use.Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.Endocannabinoid signaling in the etiology and treatment of major depressive illness.Comparison of a low-energy diet and a very low-energy diet in sedentary obese individuals: a pragmatic randomized controlled trial.Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology.Rimonabant-induced depression in schizophrenia.
P2860
Q21296814-428CEE06-8E04-47B1-B133-905DBF1E0819Q24594774-EFB1F733-7193-40A7-9D3B-4E6B83AD8F06Q24603596-58587BD5-66F7-42BC-9AFF-AD3D082522BBQ24623244-AB3251E9-F06A-4C05-AC34-F614A06311B0Q24630947-852E0548-BC00-4AA9-91A1-3FA1306E0E5AQ24631740-1E1F7AE1-0DFF-47B8-B7E3-D243B8628E56Q26745261-6A6D48E3-88DD-4972-BC17-CA52408242D3Q26767356-EE056757-3089-4D84-8171-ED2A3C7D3FAEQ26774088-3377936A-350B-4BC9-8343-DB6137FCBC02Q26774747-9832F1F9-54EF-406B-940B-983DC174C4C5Q26850858-D810C513-E9B7-4B63-929F-1CDEB0EED181Q26863500-31C95CD5-9DF5-403E-B002-D5E25F6BDF9FQ27000340-A13041F6-769D-410F-A7CB-E44ABC4F3D41Q27009466-482BE47F-CEFC-4164-A0E3-646CC081C285Q28078534-FCB3699F-8960-4E19-BA24-C70767DD4A48Q28249593-917B6392-8BF2-4991-A00F-D7B738C4D71BQ28283718-D4F4BF38-F554-4450-BA8E-157B6ADC692EQ28286488-E46776FE-7A43-4997-8C48-16FF17B9AC55Q28389088-7F392EA8-DE9E-4C60-8258-42EF746F790FQ28475155-86E64670-D2DA-4DDE-B4FD-4A193DBA1C52Q28551556-922D11CF-3801-48BE-8263-F053F63E6DC7Q28552474-480D39A0-DEB5-4EFC-8816-178054A6B15CQ29042501-C5FBF8BD-30EE-469F-B501-0EDE74DAA973Q29042705-9933818F-72E9-481D-80A2-E06CF117B335Q30243992-6339A996-4C2C-47AC-9B5E-B2D925F8A2F7Q30351879-640C1F76-61AB-497A-B453-BA47745A8051Q30353872-F3BFB14B-C548-4871-90DD-DFBCB13C8459Q30357431-AB68D574-93AE-43B4-935B-23C4A2EF7568Q30366747-838AC3E5-FCF4-4239-A590-F66FCC738D8CQ30366949-B4444177-167F-44E6-A5EF-3FD2592A9777Q30374324-9935D060-5157-4B64-9D33-EFBDD0AEA8F0Q30401145-E29F826E-26C1-4909-9B5F-0A8303A99FA9Q30402136-7C8C673B-C80B-4411-9107-AAA2860FFC0FQ30430798-2A9BB535-D653-4FF9-AD45-5533F1834752Q30497212-7113CC92-EE61-4FB7-BC6B-13FA36BD03BFQ30569742-566DFEC8-E4AD-497B-8A45-26DD5922459DQ30687668-CEB06EEA-56B6-419F-844A-88B31F3F0A5BQ33463914-633C4EAF-D1D1-4F27-A7F6-20DFDFB52365Q33509626-F18BE1C1-2D1C-49EB-B37D-BAE20DE16BEEQ33692174-7412146B-7CCB-4A8D-BBAE-9A0144A1467A
P2860
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Efficacy and safety of the wei ...... analysis of randomised trials.
@en
Efficacy and safety of the wei ...... analysis of randomised trials.
@nl
type
label
Efficacy and safety of the wei ...... analysis of randomised trials.
@en
Efficacy and safety of the wei ...... analysis of randomised trials.
@nl
prefLabel
Efficacy and safety of the wei ...... analysis of randomised trials.
@en
Efficacy and safety of the wei ...... analysis of randomised trials.
@nl
P2093
P1433
P1476
Efficacy and safety of the wei ...... analysis of randomised trials.
@en
P2093
Else Marie Bartels
Henning Bliddal
Pernelle Kruse Kristensen
Robin Christensen
P304
P356
10.1016/S0140-6736(07)61721-8
P407
P50
P577
2007-11-01T00:00:00Z